News
J&J: ‘Tripledemic’ fueled demand for Motrin and Tylenol Johnson & Johnson’s over-the-counter business had sales of $1.57 billion in the fourth quarter of 2022, beating the FactSet consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results